Sinopharm Group Co. Ltd.
Sinopharm Group Co. Ltd. (1099.HK) Stock Competitors & Peer Comparison
See (1099.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 1099.HK | HK$20.92 | +2.05% | 65.3B | 8.05 | HK$2.60 | +3.53% |
| 2607.HK | HK$11.94 | +2.31% | 69.3B | 6.82 | HK$1.75 | +3.65% |
| 2192.HK | HK$8.61 | -1.03% | 6.4B | 16.88 | HK$0.51 | +3.20% |
| 1931.HK | HK$1.12 | -0.88% | 1.8B | 9.33 | HK$0.12 | N/A |
| 2289.HK | HK$5.81 | +0.00% | 627.5M | 11.86 | HK$0.49 | +8.42% |
| 9955.HK | HK$0.72 | +2.86% | 464.9M | -0.39 | -HK$1.83 | N/A |
| 0673.HK | HK$0.52 | +0.00% | 252.9M | -5.20 | -HK$0.10 | N/A |
| 0718.HK | HK$0.03 | -9.09% | 157.5M | -0.23 | -HK$0.13 | N/A |
| 8372.HK | HK$0.13 | +2.34% | 104.8M | 13.10 | HK$0.01 | +1.91% |
| 0401.HK | HK$0.11 | +0.89% | 63.4M | -11.30 | -HK$0.01 | N/A |
Stock Comparison
1099.HK vs 2607.HK Comparison April 2026
1099.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1099.HK stands at 65.3B. In comparison, 2607.HK has a market cap of 69.3B. Regarding current trading prices, 1099.HK is priced at HK$20.92, while 2607.HK trades at HK$11.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1099.HK currently has a P/E ratio of 8.05, whereas 2607.HK's P/E ratio is 6.82. In terms of profitability, 1099.HK's ROE is +0.09%, compared to 2607.HK's ROE of +0.08%. Regarding short-term risk, 1099.HK is more volatile compared to 2607.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1099.HK.Check 2607.HK's competition here